Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
FS KKR Capital Corp Q3 2025 Earnings Call - Steady Dividend Strategy and Resilient Portfolio Amid Interest Rate Shifts
FS KKR Capital Corp reported a solid third quarter 2025 with net investment income (NII) of $0.57 per share and a slight increase in net asset value per share to $21.99. The company continues to empha...
- FSKK generated net investment income of $0.57 per share in Q3 2025, matching guidance.
- Net asset value per share increased slightly to $21.99 at quarter-end.
- The board approved a Q4 distribution of $0.70 per share, combining a $0.64 base and a $0.06 supplemental distribution.
- +12 more takeaways
Kelly Services Q3 2025 Earnings Call - Navigating macro headwinds while accelerating integration and AI-driven growth opportunities
Kelly Services reported a 9.9% revenue decline in Q3 2025, largely due to reduced demand from the federal government and three top customers, accounting for an 8% impact. Despite headwinds, select are...
- Kelly Services’ Q3 2025 revenue declined 9.9% year-over-year, impacted significantly by reduced federal and large customer demand (~8%).
- Underlying revenue excluding those discrete impacts declined 2%, aligning with general industry trends amid a sluggish labor market.
- Education segment continues growth with a 0.9% revenue increase and achieved a record 90% fill rate, although growth is moderating as client portfolios mature.
- +10 more takeaways
Ralph Lauren Q2 FY2026 Earnings Call - Strong Execution Drives Raised Full-Year Outlook Amid Macro Caution
Ralph Lauren reported a robust Q2 fiscal 2026 marked by a 14% constant currency revenue growth, surpassing expectations and achieving the highest Q2 revenue since embarking on their elevation journey ...
- Ralph Lauren delivered 14% constant currency revenue growth in Q2, surpassing high single-digit outlook.
- All three geographic regions contributed to growth, with Asia leading at 16%, including over 30% growth in China.
- Retail comps increased 13% globally, driven by balanced growth across stores and digital channels.
- +12 more takeaways
MetLife 3Q 2025 Earnings Call - Strong Investment Margins and Record Pension Risk Transfer Growth
MetLife delivered robust third-quarter 2025 results highlighted by a 21% increase in adjusted EPS to $2.34, driven primarily by elevated variable investment income and broad-based volume growth. The c...
- MetLife posted adjusted earnings of $1.6 billion, or $2.34 per share, a 21% increase year-over-year excluding notable items.
- Variable investment income reached $483 million, surpassing the $425 million guidance, driven by 3% private equity returns.
- The adjusted return on equity, excluding notables, was 16.7%, near the top of their 15%-17% target range.
- +12 more takeaways
Novavax Q3 2025 Earnings Call - Strategic Transition and Partnership-Driven Growth with Sanofi
Novavax's Q3 2025 call detailed a company in transformation, shifting from a COVID-19 vaccine commercialization model to a partnership-led, R&D innovation powerhouse. The completion of US and EU marke...
- Novavax transitioned from direct COVID-19 vaccine commercialization to a partnership and R&D innovation-led business model, highlighted by Sanofi taking lead commercial responsibility in the US and select ex-US markets.
- In 2025, Novavax achieved $225 million in milestones from Sanofi related to BLA approvals and marketing authorization transfers for Nuvaxovid, generating $4 million in royalties in Q3.
- The Sanofi partnership expanded to include Novavax’s Matrix-M adjuvant in Sanofi’s pandemic influenza vaccine candidate, which received a BARDA grant and is advancing through early clinical phases.
- +12 more takeaways
Acadia Healthcare Q3 2025 Earnings Call - EBITDA Guidance Cut Amid Medicaid Volume Headwinds and Capital Discipline
Acadia Healthcare reported Q3 2025 revenues of $851.6 million, up 4.4% year-over-year, but adjusted EBITDA dropped to $173 million from $194.3 million a year ago. Volume softness in Medicaid, especial...
- Acadia Healthcare's Q3 2025 revenues rose 4.4% year-over-year to $851.6 million, but adjusted EBITDA fell to $173 million, below prior year and expectations due to volume softness and increased costs.
- Same-facility volume growth was 1.3% in Q3, about 100 basis points below internal targets, with Medicaid acute care volumes particularly weak.
- Adjusted EBITDA guidance for full-year 2025 was lowered to $650-$660 million from $675-$700 million due to Medicaid payer pressures, increased denials, bad debt, and rising professional/general liability expenses.
- +9 more takeaways
Arhaus Q3 2025 Earnings Call - Record Revenue and Demand Despite Tariff Challenges
Arhaus reported its highest-ever Q3 net revenue at $345 million, up 8% year-over-year, powered by strong showroom expansion, record demand for the fall 2025 collection, and resilient high-end clients....
- Arhaus achieved a record Q3 net revenue of $345 million, up 8% YoY, near the high end of guidance.
- Comparable demand grew 4.1%, with demand-comparable growth reaching 7.4%, highlighting strong brand momentum.
- The fall 2025 collection was the strongest launch in company history, driving engagement across channels.
- +9 more takeaways
Air Products Fiscal 2025 Earnings Call - Focus on Core Business, CapEx Discipline, and Project Portfolio Optimization
Air Products reported fiscal 2025 earnings per share of $12.03, exceeding guidance midpoint, with operating margins and return on capital consistent with company targets. The management emphasized a r...
- Fiscal 2025 EPS of $12.03 beats guidance midpoint; operating margin at 23.7%, ROC at 10.1%.
- 43rd consecutive year of dividend increase; returned $1.6 billion to shareholders in fiscal 2025.
- Strategic focus on core industrial gas business targeting earnings growth through productivity, pricing, operational excellence, and disciplined CapEx.
- +12 more takeaways
Tronox Q3 2025 Earnings Call - Navigating Market Challenges with Cost Cuts and Strategic Patience
Tronox's Q3 2025 earnings revealed a company wrestling with weaker-than-expected demand, fierce competitive pressures, and unexpected market headwinds—especially in China and India. Despite a $99 mill...
- Q3 revenue fell 13% year-over-year to $699 million due to lower volumes and price declines in TiO2 and zircon products.
- Reported a net loss attributable to Tronox of $99 million, including $27 million restructuring charges related to Botlek closure.
- Adjusted EBITDA dropped 48% year-over-year to $74 million with a margin of 10.6%, pressured by pricing, volumes and rising freight and production costs.
- +7 more takeaways
Bloomin' Brands Fiscal Third Quarter 2025 Earnings Call - Outback Steakhouse Turnaround Strategy and Positive Comparable Sales Momentum
Bloomin' Brands delivered a cautiously optimistic fiscal Q3 2025 report, highlighting positive comparable sales momentum across all brands, including Outback Steakhouse's first positive comps since Q2...
- Q3 2025 comparable sales rose 1.2%, traffic down slightly by 0.1%, marking sequential improvement from Q2.
- Outback Steakhouse posted positive comps (+0.4%) and flat traffic for the first time since Q2 2023, driven by the Aussie Three Course value offering.
- All four casual dining brands achieved positive comp sales growth, signaling broad-based operational improvement.
- +12 more takeaways